112 related articles for article (PubMed ID: 38639057)
1. [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration].
Wang Q; Song B; Hao S; Xiao Z; Jin L; Zheng T; Chai F
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):981-988. PubMed ID: 38862457
[TBL] [Abstract][Full Text] [Related]
2. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract][Full Text] [Related]
3. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration.
Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L
Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of the TRAF family genes and their correlation with prognosis, TME, immune and drug sensitivity.
Yao B; Hu W; Chen Y; Li J; Jiang K; Dou J
Eur J Med Res; 2024 Jun; 29(1):307. PubMed ID: 38825674
[TBL] [Abstract][Full Text] [Related]
6. The pan-cancer multi-omics landscape of key genes of sialylation combined with RNA-sequencing validation.
Wu Z; Wang Z; Wu H; Zheng N; Huang D; Huang Z; Han H; Bao J; Xu H; Zhang R; Du Z; Wu D
Comput Biol Med; 2023 Nov; 166():107556. PubMed ID: 37801920
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value and immunological role of MVP in pan-cancer study.
Li C; Gao M; Zha N; Guo G
Aging (Albany NY); 2024 May; 16(10):8497-8510. PubMed ID: 38713157
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
[TBL] [Abstract][Full Text] [Related]
9. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
Milosevic V; Östman A
Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
[TBL] [Abstract][Full Text] [Related]
10. Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8
Wu Z; Su R; Dai Y; Wu X; Wu H; Wang X; Wang Z; Bao J; Chen J; Xia E
Comput Biol Med; 2024 Jul; 177():108666. PubMed ID: 38820773
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology.
Ostojić M; Đurić A; Živić K; Grahovac J
PLoS One; 2024; 19(5):e0299685. PubMed ID: 38781180
[TBL] [Abstract][Full Text] [Related]
12. TREM2 Is a Prognostic Biomarker and Correlated with an Immunosuppressive Microenvironment in Thyroid Cancer.
Wang J; Li Z
Dis Markers; 2022; 2022():1807386. PubMed ID: 36438899
[TBL] [Abstract][Full Text] [Related]
13. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions.
Ham J; Wang B; Po JW; Singh A; Niles N; Lee CS
J Clin Pathol; 2021 Dec; 74(12):759-765. PubMed ID: 33619218
[TBL] [Abstract][Full Text] [Related]
15. Immune Landscape of Thyroid Cancers: New Insights.
Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
[TBL] [Abstract][Full Text] [Related]
16. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
17. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]